Company News: Page (1) of 1 - 10/05/17 Email this story to a friend. email article Print this page (Article printing at page facebook

Tolero Pharmaceuticals to Deliver Keynote Presentations at the 9th International Conference on Leukemia and Hematologic Oncology

CEO, David J. Bearss, and VP of Discovery and Development, Steven L. Warner, to share insights on targeting MCL-1 dependent cancers and novel kinases in hematologic malignancies (October 05, 2017)
This article is no longer available,but here are some related topics.

Page: 1

Related Keywords:Pro AV,Presentors,Business,Business Issues,Presentation,Events, Inc.,Medicine,Surgery,Science,Lifestyle,Medical,Biology,Genetics,Cancer,Business,Other,

[ServletException in:/common/ads/links.jsp] Unable to load class for JSP'

Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved